Livingstone Chishimba

Suggest Changes
Learn More
BACKGROUND AND RATIONALE Antifungal therapy for severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA) remains poorly studied. We assessed the efficacy and(More)
  • 1